1. Excellence in Translational Medicine Award
2. Bedside to Bench Award
Excellence in Translational Medicine Award
Sponsored by Medistem and an anonymous donor, and supported by the Journal of Translational Medicine Editorial Board.*
Award
The Excellence in Translational Medicine Award endeavors to recognize outstanding contributions to the field of translational medicine research as well as encouraging and rewarding those investigators who are devoted to improving the efficiency in which biomedical research is performed, with the ultimate goal of preventing disease. The winner of the Excellence in Translational Medicine Award will receive a $5,000 prize to cover the expenses for any meeting sponsored by a non-for-profit organization, that is relevant to the purposes of translational medicine/research.
Eligibility Criteria
- *The award will be granted to the first author of a Research or Methodology manuscript containing original data published in the Journal of Translational Medicine between 1st July 2009 and 30th June 2010
- Candidates may be self-nominated, or nominated by a colleague
- Candidates must be the primary clinician or scientist involved in the project described by the article. If there are multiple first authors, each first author may claim designation as a candidate. In the event of multiple authors sharing the award, the prize will be divided equally
- Authors from the laboratories of members of the selection committee are not eligible for the award
Evaluation Criteria
Submitted articles will be evaluated with regard to:
- Relevance to the purposes of translational medicine/research translating new ideas into patient care (bench to bedside) and/or discovery-driven, evidence-based studies aimed at the understanding of human pathology by the direct study of human subjects (bedside to bench)
- Scientific merit
- Sound research design
- Rigorous methodology
- Originality
- Clarity
How to apply for Excellence in Translational Medicine Awared
All applications should be made via the following online application form. Candidates may be self-nominated, or nominated by others. Nominations must be received between 1st July 2009 and 30th June 2010.
Selection Committee
Selection will be made by a committee of volunteer members of the Editorial Board, with the final decision resting with the Editor-in-Chief.
For questions, please contact:
Francesco M Marincola,
Editor-in-Chief
Journal of Translational Medicine
FMarincola@cc.nih.gov
*Editorial decisions are made by the Editorial Board, independent of the sponsor.
Previous winners
In previous years the Excellence in Translational Medicine Award was awarded to the authors of the following articles:
Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models
Xinmei Zhu, Fumihiko Nishimura, Kotaro Sasaki, Mitsugu Fujita, Jill E Dusak, Junichi Eguchi, Wendy Fellows-Mayle, Walter J Storkus, Paul R
Walker, Andres M Salazar, Hideho Okada
Journal of Translational Medicine 2007, 5:10 (12 February 2007)
A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy
Louise R Rodino-Klapac, Paul ML Janssen, Chrystal L Montgomery, Brian D Coley, Louis G Chicoine, K Reed Clark, Jerry R Mendell
Journal of Translational Medicine 2007, 5:45 (24 September 2007)
Diagnosis of drug-induced renal tubular toxicity using global gene expression profiles
Ying Jiang, David L Gerhold, Daniel J Holder, David J Figueroa, Wendy J Bailey, Ping Guan, Thomas R Skopek, Frank D Sistare, Joseph F Sina
Journal of Translational Medicine 2007, 5:47 (1 October 2007)
|